Skip to the page

Data / Form D filings / JelliSee Ophthalmics Inc.

JelliSee Ophthalmics Inc.: Form D filings

JelliSee Ophthalmics Inc., a biotechnology company in Mclean, VA, filed 2 Form D notices with the SEC in 2024. The latest, on April 30, 2024, reports $3.7 million sold of a $10 million offering to 34 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8414 HOLLY LEAF DR., Mclean, VA, 22102
Phone
(610) 640-5435
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2006388

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 30, 2024Amendment$10,000,000$3,725,000$6,275,00034Dec 21, 2023sec.gov
Jan 5, 2024New notice$10,000,000$1,675,000$8,325,00015Dec 21, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jerry J. ArthurDirector
Michael J. MalesardiExecutive Officer, Director
Forrest J EllisExecutive Officer, Director
Amy R. JefferyExecutive Officer, Director
Adrienne J. GravesDirector
Dimitri J. AzarDirector

Other biotechnology companies in Virginia that filed recently

Every Form D from the week of Apr 29, 2024 · All recent filings in Virginia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what JelliSee Ophthalmics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.